Atopy, allergy and eczema

All Items

• Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients

  Min Jae Kim, Bo Ri Kim, Sae Hoon Kim, Yoon Seok Chang, Sang Woong Youn

  adv11627

• Clinically Meaningful Improvement in Atopic Dermatitis According to Treatment Type in a Real-World Cohort

  Emanuel Chew Bonilla, Yazmín Xurami Vega-Del Pilar, Eduardo Vilchis Chaparro, Alicia Lemini López

  adv-2026-0422

• Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial

  Michael J. Cork, Benjamin Lockshin , Andreas Pinter , Zhen Chen , Brad Shumel , Randy Prescilla

  adv13467

• Colophonium-related Allergic Contact Dermatitis Caused by Medical Adhesive Tape Used to Prevent Skin Lesions in Soldiers

  Nils Hamnerius, Jakob Dahlin, Magnus Bruze, Kristina Nilsson, Thanisorn Sukakul, Cecilia Svedman

  adv18428

• Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis

  Farnam B. Sedeh, Mattias A.S. Henning, Gregor B.E. Jemec, Kristina S. Ibler

  adv00764

• Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden

  Josefin Ulriksdotter, Thanisorn Sukakul, Magnus Bruze, Martin Mowitz, Robert Ofenloch, Cecilia Svedman

  adv19676

• Contact Allergy to Oxidized Linalool and Oxidized Limonene is Over-represented in Individuals with Photocontact Allergy to Ketoprofen

  Magnus Bruze, Victoria Marmgren, Annarita Antelmi, Monica Hindsén Stenström, Cecilia Svedman, Erik Zimersson, Martin Mowitz

  adv00454

• Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation

  Alexandra Junge, Susanne Radonjic-Hoesli, Simon Bossart, Dagmar Simon, Pierre de Viragh, Robert E. Hunger, Kristine Heidemeyer, S. Morteza Seyed Jafari

  adv42401

• Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis

  Elise Cabout, Sébastien Eymere, Robert Launois, Sophie Séité, Véronique Delvigne, Charles Taïeb, Ziad Reguai

  adv00509

• Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment

  Catalina H. Skovsgård , Anne Sofie Frølunde, Mette Deleuran , Jacob P. Thyssen, Simon F. Thomsen, Christian Vestergaard

  adv42544

• Cross-Cultural Validation of the RECAP of Atopic Eczema Question­naire in a Swedish Population

  Gunnthorunn Sigurdardottir, Mikael Alsterholm, Chris D. Andersson, Maria Bradley, MariHelen Sandström Falk, Emma K. Johansson, Maria Lundqvist, Andreas Sonesson, Åke Svensson, Grigorios Theodosiou , Sophie Vrang, Laura B. von Kobyletzki

  adv38889

• Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry

  Celeste M. Boesjes, Esmé Kamphuis, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Laura Loman, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Anneke M.T. van Lynden-van Nes, Floor M.Garritsen, Klaziena Politiek, Marja Oldhoff, Marlies de Graaf, Marie L.A. Schuttelaar , Marjolein S. de Bruin-Weller

  adv00820

• Definition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi Consensus

  Juan-Manuel Liñán-Barroso, Juan-Carlos Hernández-Rodríguez, Ricardo Ruiz-Villaverde, Manuel Galán-Gutiérrez, Francisco Navarro-Triviño, Javier Domínguez-Cruz, José-Carlos Armario-Hita, Jose-Juan Pereyra-Rodriguez

  adv42240

• Dermatology Life Quality Index as a Prognostic Tool for Predicting Need for Healthcare in Patients with Eczema: A Pilot Study

  Wasim Jamil, Laura von Kobyletzki, Mats Berg, Magnus Lindberg

  adv00673

• Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach

  Carsten Spitzer, Ines Buchholz, Laura Lübke, Clara Wülfing, Katharina Meier, Georgios Kokolakis, Dennis Niebel, Caroline Mann, Ante Karoglan, Steffen Emmert, Alexander Thiem

  adv42794

• Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children

  Trine Gerner, Maria Rasmussen Rinnov, Anne-Sofie Halling, Nina Haarup Ravn, Mette Hjorslev Knudgaard, Caroline Ewertsen, Simon Trautner, Ivone Jakasa, Sanja Kezic, Lone Skov, Jacob P. Thyssen

  adv00737

• Does Molluscum Contagiosum Need to be Managed Differently in Atopic Children?

  Nicolas Andre, Adva Alyagon, Eman Jurban, Khen Moscovici, Amir Horev

  adv39983

• Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort

  Pontus O. Jonsson, Mahsa Tayefi, Axel Svedbom, Maria Bradley, Emma K. Johansson

  adv43464

• Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis

  Takayuki Tanji, Daisuke Watabe, Nobuyuki Arakawa, Hirofumi Kamada, Hiroo Amano

  adv5326

• Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation

  Saori Takamura, Tomoo Fukuda

  adv43999

• Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis

  Jonathan I. Silverberg, Eric L. Simpson, Mark Boguniewicz, Marjolein S. De Bruin-Weller, Peter Foley, Yoko Kataoka, Gaëlle Bégo-Le-Bagousse, Zhen Chen, Brad Shumel, Jingdong Chao, Ana B. Rossi

  adv00585
• 

  Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis

  Andreas Wollenberg, Danielle Marcoux, Jonathan I. Silverberg, Valeria Aoki, Eulalia Baselga, Haixin Zhang, Noah A. Levit, Alain Taieb, Ana B. Rossi

  adv00726

• Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use

  Mette Deleuran, Danielle Marcoux, Marjolein S. De Bruin-Weller, Alan D. Irvine, Eulalia Baselga, Kangmo Ahn, Ana Paula Castro, Ashish Bansal, Jingdong Chao, Gaëlle Bégo-Le-Bagousse, Ana B. Rossi

  adv00504

• Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series

  Louise Lönndahl, Maria Lundqvist, Maria Bradley, Emma K. Johansson

  adv00754

• Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis

  LiMing Wu, Kamran Ali, YunMi Qiu, MengHua Li, JiaYang Da

  adv00743

• Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis

  Roselie Achten, Lisa van der Rijst, Marjanne Piena, Hedda Lamers, Fleur de Beer, Marjolein de Bruin-Weller, Marlies de Graaf

  adv00881

• Economic Burden of Atopic Dermatitis in Taiwan

  Ellen M. Lee, Yung-Tsu Cho, Tom C. Chan, Dereck Shen, Chia-Yu Chu, Chao-Hsiun Tang

  adv00866

• Eczema-related Web Search Data in Sweden: Investigating Search Patterns and the Influence of Weather

  Linda Tizek, Hannah Wecker, Simon Schneider, Emma K. Johansson, Yodit Girmay, Alexander Zink

  adv00810

• Effect of Disease Severity on Comorbid Conditions in Atopic Dermatitis: Nationwide Registry-Based Investigation in Finnish Adults

  Ville Kiiski, Liisa Ukkola-Vuoti , Johanna Vikkula , Martta Ranta, Mariann I. Lassenius , Jaakko Kopra

  adv00882

• Effect of Paediatric Atopic Dermatitis on Parental Sleep Quality

  Ester Forer, Inbal Golan Tripto, Romi Bari, David Shaki, Aviv Goldbart, Amir Horev

  adv00879

• Effect of Potassium Permanganate on Staphylococcal Isolates Derived from the Skin of Patients with Atopic Dermatitis

  Sigrid Lundgren, Andreas Sonesson

  adv18642

• Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs

  Marine Fargeas, Mathieu Fauvernier, Marie Tauber, Julien Seneschal, Virginie Verdu, Magali Bourrel Bouttaz, Florence Hacard, Anne-Sophie Darrigade, Audrey Nosbaum

  adv41184

• Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study

  Laura Calabrese, Elisa Cinotti, Martina D’Onghia, Alessandra Cartocci, Pietro Rubegni, François Maccari , Claire Boulard, Ziad Reguiai, Pierre-André Becherel, Caroline Jacobzone, Edouard Begon, Charlotte Fite, Beatrice Walls, Anne Laure Liegeon, Josiane Parier, Guillaume Chaby, Jean-Luc Perrot

  adv42275

• Effectiveness of Baricitinib in Treating Atopic Dermatitis in Difficult-to-treat Areas: A Retrospective Real-world Study

  Giuseppe Lauletta, Maddalena Napolitano, Claudio Brescia, Francesca di Vico, Melania Parisi, Cataldo Patruno

  adv-2026-0386

• Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

  Celeste M. Boesjes, Liana F. van der Gang, Nicolaas P.A. Zuithoff, Daphne S. Bakker, Lotte S. Spekhorst, Inge Haeck, Marijke Kamsteeg, Marlies de Graaf, Marjolein S. de Bruin-Weller

  adv00872

• Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study

  Inken Harder, Dora Stölzl, Nicole Sander, Jan Hartmann, Elke Rodriguez, Carsten Mazur, Sebastian Kerzel, Michael Kabesch, Denise Küster, Jochen Schmitt, Regina Fölster-Holst, Sascha Gerdes, Hila Emmert, Stephan Weidinger

  adv5671

• Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways

  Tae-Young Gil, Bo-Ram Jin, Yea-Jin Park, Hye-Min Kim, Hyo-Jin An

  adv11593

• Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)

  Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, Piergiorgio Malagoli, Alessandra Narcisi, Silvia M. Ferrucci, Giampiero Girolomoni, Anna Balato, Flavia Manzo Margiotta, Claudio Sciarrone, Caterina Foti, Massimo Gola, Maria Esposito, Maddalena Napolitano, Carlotta Gurioli, Michela Ortoncelli, Francesca Satolli, Maria L. Musumeci, Paola Savoia, Fabrizio Amoruso, Anna G. Burroni, Cristina Beatrice Spigariolo, Piergiacomo Calzavara-Pinton, Antonio Costanzo, Luigi Gargiulo, Francesca Barei, Martina Maurelli, Marco Romanelli, Federica Veronese, Benedetta Tirone, Maria C. Fargnoli, Cataldo Patruno, Simone Ribero, Marco Vaccino, Luigi Naldi

  adv-2025-0193

• Efficacy and Safety of Abrocitinib in an Elderly Chinese Population with Moderate-to-Severe Atopic Dermatitis: A Non-randomized Controlled Trial

  Quanhong Zhang, Yue Zhu, Luoyao Yang, Yueping Zeng, Hongmei Zhang, Lang Yu, Gang Hu, Lei Hu, Liuqing Chen, Jinbo Chen

  adv44200

• Efficacy and Safety of Dupilumab vs Narrowband UVB for the Treatment of Chronic Hand Dermatitis: A Retrospective Study

  Miranda K. Branyiczky, Noor Sakka, Mohammed Bawazir, Ajith Cy, Mohannad Abu-Hilal

  adv42198

• Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis

  Andreas Wollenberg, Jonathan I. Silverberg, Franz J. Legat, Marie Tauber, Vivian T. Laquer, April W. Armstrong, Andrew E. Pink, Luigi Naldi, Grażyna Pulka, Jacek Zdybski, Athanasios Tsianakas, Jorge Diaz, Inese Svarca, Jennifer Beecker, Galina Balakirski, Sylvia Pauser, Liliana Ulianov, Anna Ryzhkova, Jean-Loup Machu, Christophe Piketty

  adv-2025-0085

• Efficacy of Acupuncture for Treatment of Atopic Eczema and Chronic Eczema: A Systematic Review and Meta-analysis

  Jhen-Yu Jwo, Katie Chiou, Jerry Tsai, Yu-Chen Huang, Chia-Yu Lin

  adv00791

• Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study

  Takeshi Nakahara, Makiko Kido-Nakahara, Daisuke Onozuka, Sawako Sakai, Tomoko Hirose, Nobutoshi Take , Akiko Sugiyama, Kayo Harada, Gaku Tsuji, Satoko Kikuchi, Futoshi Kohda

  adv00586

• Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy

  Mikael Alsterholm, Axel Svedbom, Chris D. Anderson, Lena Holm Sommar, Lina U. Ivert, Anna Josefson, Laura von Kobyletzki, Magnus Lindberg, Lena Lundeberg, Maria Lundqvist, Elisabet Nylander, MariHelen Sandström Falk, Alexander Shayesteh, Gunnthorunn Sigurdardottir, Andreas Sonesson, Åke Svensson, Marie Virtanen, Sophie Vrang, Carl-Fredrik Wahlgren, Maria Bradley, Emma K. Johansson

  adv7312

• Establishment of a Nationwide Patient Database for Clinical Trial Recruitment in Dermatology: Concept and Patient Characteristics

  Dorra Bouazzi, Anette Bygum, Lone Skov, Mikkel Lindskov Sachs, Lars Iversen, Merete Hædersdal, Gregor B.E. Jemec, Simon F. Thomsen

  adv00461

• Euthyroid Pretibial Mucinous Dermatoses: A Systematic Review of Current Evidence and the Controversy Surrounding Their Classification

  Ghassan Barnawi, Raquel Lazarowitz, Ammar Saed Aldien, Tammam Alanezi, Ivan V. Litvinov

  adv44322

• Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion

  Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, Alain Delarue

  adv11954

• Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

  Jonathan I. Silverberg, Anna M. Tallman, William C. Ports, Robert A. Gerber, Huaming Tan, Michael A. Zielinski

  adv00170

• Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study

  Hyun Ji Lee, Yuri Woo, Young Bok Lee, Ji Hye Lee, Jung Eun Kim, Ji Hyun Lee, Sang Hyun Cho

  adv40704

• Exploring Capsaicin and Cinnamaldehyde for Scratching Behaviour in Mice: Effects of Sex, Concentration and Time Course

  Rosane Schenkel de Aquino, Aledson Rosa Torres, Alcir Luiz Dafre, Adair Roberto Soares Santos

  adv9642